Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test

Journal of Clinical Microbiology

Volumn 34, Issue 12, 1996, Pages 2997-3001

  Sanders, Christine C ^a   Barry, Arthur L ^b   Washington, John A ^c   Shubert, Carole ^d   Moland, Ellen S ^a   Traczewski, Maria M ^b   Knapp, Cynthia ^c   Mulder, Ross ^d  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BioMerieux Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CHROMOSOME ANALYSIS; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE STRUCTURE; HYDROLYSIS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; PRIORITY JOURNAL; RELIABILITY;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE;

EID: 0029860728     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.12.2997-3001.1996     Document Type: Article

References (26)

1. Bradford, P. A., N. V. Jacobus, N. Bhachech, and K. Bush. 1996. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 40:260-262.
2. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
3. Brown, D. F. J., A. Wattam, and E. Walpole. 1995. Detection of extended spectrum β-lactamases (ESBLs) with the Etest ESBL strip, abstr. D12, p. 68. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
5. Casellas, J. M., and M. Goldberg. 1989. Incidence of strains producing extended spectrum β-lactamases in Argentina. Infection 17:434-436.
6. Chardon, H., C. Pachetti, L. Collet, O. Bellon, and E. Lagier. 1993. Isoelectric point determination of beta-lactamases from 67 strains of Klebsiella oxytoca and activity of eight beta lactam antibiotics. Pathol. Biol. 41:343-348.
7. Fournier, B., P. H. Lagrange, and A. Philippon. 1996. β-Lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob. Agents Chemother. 40:460-463.
8. OXY-2. Antimicrob. Agents Chemother. 40:454-459.
9. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.
10. Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
11. Karas, J. A., D. G. Pillay, D. Muckart, and A. W. Sturm. 1996. Treatment failure due to extended spectrum β-lactamase. J. Antimicrob. Chemother. 37:203-204.
12. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J. Clin. Microbiol. 32:691-696.
13. Lucet, J.-C., S. Chevret, D. Decré, D. Vanjak, A. Macrez, J.-P. Bédos, M. Wolff, and B. Regnier. 1996. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin. Infect. Dis. 22:430-436.
14. Medeiros, A. A. 1993. Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America. Ann. Intern. Med. 119:428-430.
15. Meyer, K. S., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Rahal. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann. Intern. Med. 119:353-358.
16. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Philippon, A., R. Labia, and G. A. Jacoby. 1989. Extended-spectrum β-lactamascs. Antimicrob. Agents Chemother. 33:1131-1136.
19. Sanders, C. C., J. P. Iaconis, G. P. Bodey, and G. Samonis. 1988. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob. Agents Chemother. 32:1365-1369.
20. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-Lactam resistance in gramnegative bacteria: global trends und clinical impact. Clin. Infect. Dis. 15:824-839.
21. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
22. Sanders, C. C., K. S. Thomson, and P. A. Bradford. 1993. Problems with detection of β-lactam resistance among nonfastidious gram-negative bacilli. Infect. Dis. Clin. N. Am. 7:411-425.
23. Sirot, D. L., F. W. Goldstein, C. J. Soussy, A. L. Courtieu, M. O. Husson, J. Lemozy, M. Meyran, C. Morel, R. Perez, C. Quentin-Noury, M. E. Reverdy, J. M. Scheftel, M. Rosembaum, and Y. Rezvani. 1912. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob. Agents Chemother. 36:1677-1681.
24. Thomson, K. S. 1995. Improved detection of extended-spectrum β-lactamases (ESBLs) from disk diffusion susceptibility tests, abstr. C-87, p. 16. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
25. Thomson, K. S., A. M. Prevan, and C. C. Sanders. 1996. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics. Curr. Clin. Top. Infect. Dis. 16:151-163.
26. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877-1882.